NAIROBI, June 29 (Reuters) – Kenya has secured $ 130 million in additional funding from the World Bank to help purchase vaccines to fight the COVID-19 pandemic, the bank said Tuesday.
Like other countries across the continent, the East African nation has been hit by deadly waves of COVID-19 infections this year, forcing it to reinstate strict, partial lockdown measures.
“This additional funding comes at a critical time when the Kenyan government is making a concerted effort to contain the rising cases of COVID-19 infections,” said Keith Hansen, World Bank country director in Kenya.
The funding will help Kenya purchase vaccines through a dedicated African Union facility and through COVAX, the global program for the fair distribution of vaccines.
The funds will provide the government with “a flexible approach to selecting a portfolio of vaccines that best fits local capacities, delivery times and vaccine approvals,” said Jane Chuma, senior health economist at the World Bank.
The money will also be used to strengthen Kenya’s cold chain facilities for vaccine storage, health worker training, and other related activities.
Reporting by Duncan Miriri Editing by Mark Potter
Our Standards: The Thomson Reuters Trust Principles.